Intervacc submits Type II variation to EMA seeking 12-month duration of immunity for StrangvacCision•30/07/2026•02:30 ET0 ShareWhiz InsightsGenerateGet startedCreate a free account to read the full story.Sign UpAlready have an account? Log inForgot password?
